CJC-1295 + Ipamorelin Facts

What is CJC-1295 + Ipamorelin?

CJC-1295 and Ipamorelin are two synthetic peptides that are commonly studied together because they stimulate the body's natural production of growth hormone through complementary mechanisms.

• CJC-1295 is a Growth Hormone-Releasing Hormone (GHRH) analog that stimulates the pituitary gland to release growth hormone.
• Ipamorelin is a Growth Hormone Secretagogue Receptor (GHSR) agonist, also known as a ghrelin receptor agonist, that promotes growth hormone release through a different signaling pathway.

Together, they have been investigated for their potential to increase endogenous growth hormone secretion while preserving the body's natural pulsatile release pattern.

Basic Information

• Peptide Class:
  • CJC-1295: Growth Hormone-Releasing Hormone (GHRH) analog
  • Ipamorelin: Growth Hormone Secretagogue (GHS) / Ghrelin receptor agonist
• Administration: Typically investigated via subcutaneous injection
• Primary Target:
  • CJC-1295: GHRH receptors in the anterior pituitary
  • Ipamorelin: Growth Hormone Secretagogue Receptors (GHSR)
• Research Focus: Endogenous growth hormone stimulation

Mechanism of Action

CJC-1295 stimulates the pituitary gland through the GHRH receptor, promoting the release of growth hormone.

Ipamorelin activates the ghrelin receptor (GHSR), triggering an additional signal for growth hormone secretion.

Because these peptides act through different receptors, researchers have investigated whether their combined use may produce a greater growth hormone response than either peptide alone.

The released growth hormone subsequently stimulates production of Insulin-like Growth Factor-1 (IGF-1), primarily in the liver.

Areas of Research

Researchers have investigated CJC-1295 and Ipamorelin for their potential effects on:

Growth Hormone Secretion

• Increased endogenous growth hormone release.
• Support for natural pulsatile GH secretion.
• Increased circulating IGF-1 levels.

Body Composition

Clinical and preclinical research has explored whether elevated GH and IGF-1 levels may influence:

• Lean body mass.
• Fat metabolism.
• Muscle preservation.

Evidence for these outcomes remains limited and continues to be investigated.

Exercise Recovery

Researchers have explored whether increased endogenous growth hormone secretion may influence:

• Recovery following exercise.
• Connective tissue remodeling.
• Muscle repair.
• Tendon and ligament physiology.

More research is needed to determine clinical significance.

Sleep Physiology

Growth hormone is naturally released during deep sleep.

Researchers have investigated whether stimulating endogenous GH release may influence sleep quality and overnight hormone secretion.

Results have been mixed.

Healthy Aging Research

Growth hormone and IGF-1 play important roles in:

• Protein synthesis.
• Tissue maintenance.
• Cellular growth.
• Bone metabolism.

Researchers continue to study how modulation of these pathways may influence healthy aging, although no therapeutic conclusions have been established.

Why Are They Commonly Studied Together?

CJC-1295 and Ipamorelin stimulate growth hormone release through different biological pathways.

Researchers have hypothesized that combining them may:

• Produce greater GH release than either peptide alone.
• Increase IGF-1 production.
• Better mimic natural endocrine physiology.

These potential effects remain under investigation.

Human Research

Small clinical studies involving GHRH analogs and growth hormone secretagogues have demonstrated:

• Increased circulating growth hormone.
• Increased IGF-1 concentrations.
• Generally favorable tolerability under controlled research settings.

However, large, long-term clinical trials evaluating clinical outcomes remain limited.

Research Use Only: This product is intended exclusively for laboratory and scientific research by qualified professionals. It is not intended for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease. This product has not been evaluated or approved by the U.S. Food and Drug Administration (FDA). Handle and store in accordance with applicable laboratory safety procedures.